Our study suggests that while tumor-derived EVs containing oncogenic H-ras may trigger unique biological responses, some reminiscent of malignant transformation, these effects are restricted in scope and duration, and unable to trigger tumorigenic conversion of indolent cells. Here, HRAS is linked to neoplasm.